About: pharmaceuticals

Health 10-10-2017

Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.
Economy & Jobs 04-08-2017

Anti-monopolies economist: ‘Innovation breeds inequality’

Inequality is an inevitable side effect of innovation and many monopolies could be broken by simply eliminating patents, insists Italian economist Michele Boldrin. EURACTIV’s partner El País – Planeta Futuro reports.
Health 22-02-2017

Greek pharma boss: Patients are punished when innovation is penalised

Patients are “punished” due to a lack of innovation-driven structural reforms in a crisis-hit public health system, the head of the Greek pharma industry said in an interview with Euractiv Greece.
Health 26-07-2016

Pharma expert: new ‘value added medicines’ offer cheaper, customised treatment

A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EURACTIV.com
Agrifood 20-11-2014

Commission official: The EU is not going to change its food legislation because of TTIP

The EU is not going to change its food safety legislation under the negotiation for the Transatlantic Trade and Investment Partnership (TTIP), which means that GMOs can be marketed in the EU only once they have been authorised, and beef from the USA would be marketable in Europe only if it is hormone free, Ignacio Garcia Bercero of the European Commission told EURACTIV Czech Republic.
Ben Goldacre
Health 22-10-2014

Ben Goldacre: Pharma industry has destroyed its own reputation

EXCLUSIVE: The great tragedy for the pharmaceutical industry is that it keeps denying that it lobbies against transparency in clinical trials, says Ben Goldacre.
Health 09-03-2012

Pharma chief: ‘Governments are hitting this industry very hard’

Europe’s debt crisis is hitting health budgets, leading to unpaid bills for pharmaceutical products, warns the head of Europe's pharma industry association, EFPIA, in an interview with EURACTIV. According to Richard Bergström, the industry is near breaking point and the issue needs to be discussed at the highest policy making levels.
Health 14-03-2011

Pharma chief: Europe must not fall behind US, emerging countries

Brian Ager, Director-General of the European Federation of Pharmaceutical Industries and Associations (EFPIA), is leaving his position after 16 years at the head of the trade association. In an interview with EURACTIV, he reflects on his tenure and discusses some of the new legislation and controversies affecting the pharmaceutical industry.
Health 26-09-2006

‘Member states want to block any change on pharmaceuticals’

The first meeting of the High Level Pharmaceutical Forum (HLPF) is set to be difficult. In order to control the health costs, the member states are likely to block any change on the topics under discussion: pricing of medicines, the assessment of relative effectiveness of drugs and information for patients, argues MEP Jorgo Chatzimarkakis in an interview with EURACTIV.